Quest Laboratories Ltd. is engaged in the business of manufacturing pharmaceutical formulations. It offers antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments and antidepressants. The firm's products include: Chlorpheniramine Maleate Tablets IP 4 mg, Metformin Hydrochloride Tablets IP 500 mg, Metronidazole Tablets IP 200 mg, Dicyclomine Hydrochloride Tablets IP 10 mg, Metformin Hydrochloride Tablets IP 500 mg, Ibuprofen Tablets Br 400 mg BRUPAIN, Paracetamol & Dicyclomine Hydrochloride Tablets, liquid orals, Cyproheptadine Hydrochloride & Tricholine Citrate Syrup, Levosalbutamol Sulphate, Ambroxol Hydrochloride & Guaiphenesin Syrup, Cypronex-T Syrup, ointments and suspension prodcuts. The company was founded on June 1, 1998 and is headquartered in Dhar, India.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company